Over 12,000 KerioControl firewalls exposed to exploited RCE flaw
Over twelve thousand GFI KerioControl firewall instances are exposed to a critical remote code execution vulnerability ...
Grace Therapeutics, Inc.: Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine New Drug Application (NDA) Submission Expected in the First Half of 2025 PRI ...